Enhanced Cytokine Synthesis of Leukocytes by a β‐Glucan Preparation, SCG, Extracted from a Medicinal Mushroom, Sparassis crispa

References

• Borchers A. T., Stern J. S., Hackman R. M., Keen C. L., Gershwin M. E. Mushrooms, tumors, and immunity. Proc. Soc. Exp. Biol. Med. 1999; 221(4)281–293
   PubMed Web of Science ®Google Scholar
• Hamano K., Gohra H., Katoh T., Fujimura Y., Zempo N., Esato K. The preoperative administration of lentinan ameliorated the impairment of natural killer activity after cardiopulmonary bypass. Int. J. Immunopharmacol. 1999; 21(8)531–540
   PubMedGoogle Scholar
• Kidd P. M. The use of mushroom glucans and proteoglycans in cancer treatment. Altern. Med. Rev. 2000; 5(1)4–27
   PubMedGoogle Scholar
• Fullerton S. A., Samadi A. A., Tortorelis D. G., Choudhury M. S., Mallouh C., Tazaki H., Konno S. Induction of apoptosis in human prostatic cancer cells with beta‐glucan (Maitake mushroom polysaccharide). Mol. Urol. 2000; 4(1)7–13
   PubMedGoogle Scholar
• Matsuoka H., Seo Y., Wakasugi H., Saito T., Tomoda H. Lentinan potentiates immunity and prolongs the survival time of some patients. Anticancer Res. 1997; 17(4A)2751–2755
   PubMedGoogle Scholar
• Taguchi T. Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer. Gan To Kagaku Ryoho 1983; 10(2)387–393
   PubMedGoogle Scholar
• Fujimoto S., Furue H., Kimura T., Kondo T., Orita K., Taguchi T., Yoshida K., Ogawa N. Clinical outcome of postoperative adjuvant immunochemotherapy with sizofiran for patients with resectable gastric cancer: a randomised controlled study. Eur. J. Cancer 1991; 27(9)1114–1118
   PubMed Web of Science ®Google Scholar
• Yadomae T. Structure and biological activities of fungal beta‐1,3‐glucans. Yakugaku Zasshi 2000; 120(5)413–431
   PubMedGoogle Scholar
• Ohno N., Miura N. N., Chiba N., Adachi Y., Yadomae T. Comparison of the immunopharmacological activities of triple and single‐helical schizophyllan in mice. Biol. Pharm. Bull. 1995; 18(9)1242–1247
   PubMedGoogle Scholar
• Ohno N., Egawa Y., Hashimoto T., Adachi Y., Yadomae T. Effect of beta‐glucans on the nitric oxide synthesis by peritoneal macrophage in mice. Biol. Pharm. Bull. 1996; 19(4)608–612
   PubMedGoogle Scholar
• Hashimoto T., Ohno N., Adachi Y., Yadomae T. Enhanced production of inducible nitric oxide synthase by beta‐glucans in mice. FEMS Immunol. Med. Microbiol. 1997; 19(2)131–135
   PubMedGoogle Scholar
• Mura N. N., Ohno N., Adachi Y., Aketagawa J., Tamura H., Tanaka S., Yadomae T. Comparison of the blood clearance of triple‐ and single‐helical schizophyllan in mice. Biol. Pharm. Bull. 1995; 18(1)185–189
   PubMedGoogle Scholar
• Hirata N., Tsuzuki A., Ohno N., Saita M., Adachi Y., Yadomae T. Cytokine synthesis of human monocytes stimulated by triple or single helical conformer of an antitumour (1 → 3)‐beta‐D‐glucan preparation. Sonifilan. Zentralbl. Bakteriol. 1998; 288(3)403–413
   PubMedGoogle Scholar
• Tateishi T., Ohno N., Adachi Y., Yadomae T. Increases in hematopoietic responses caused by beta‐glucans in mice. Biosci. Biotechnol. Biochem. 1997; 61(9)1548–1553
   PubMed Web of Science ®Google Scholar
• Schirrmacher V. Biotherapy of cancer. Perspectives of immunotherapy and gene therapy. J. Cancer Res. Clin. Oncol. 1995; 121(8)443–451
   PubMedGoogle Scholar
• Ohno N., Miura N. N., Nakajima M., Yadomae T. Antitumor 1,3‐beta‐glucan from cultured fruit body of Sparassis crispa. Biol. Pharm. Bull. 2000; 23(7)866–872
   PubMed Web of Science ®Google Scholar
• Ohno N., Harada T., Masuzawa S., Miura N. N., Adachi Y., Nakajima M., Yadomae T. Antitumor activity and hematopoietic response of a beta‐glucan extracted from the mushroom Sparassis crispa (Wulf.) Fr. Int. J. Medicinal Mushrooms 2002; 4(1)13–26
   Google Scholar
• Harada T., Miura N., Adachi Y., Nakajima M., Yadomae T., Ohno N. Effect of SCG, 1,3‐Beta‐D‐glucan from Sparassis crispa on the hematopoietic response in cyclophosphamide induced leukopenic mice. Biol. Pharm. Bull. 2002; 25(7)931–939
   PubMedGoogle Scholar
• Parkinson D. R. Cytokines in cancer therapy. Urology 1989; 34(4)69–74
   PubMedGoogle Scholar
• Lasek W., Feleszko W., Golab J., Stoklosa T., Marczak M., Dabrowska A., Malejczyk M., Jakobisiak M. Antitumor effects of the combination immunotherapy with interleukin‐12 and tumor necrosis factor alpha in mice. Cancer. Immunol. Immunother. 1997; 45(2)100–108
   PubMedGoogle Scholar
• Terlikowski S. J. Tumour necrosis factor and cancer treatment: a historical review and perspectives. Rocz. Akad. Med. Bialymst. 2001; 46: 5–18
   PubMedGoogle Scholar
• Chcialowski A., Targowski T., Bajera I., Jahnz‐Rozyk K. Tumor necrosis factor‐alpha—phase I and phase II clinical trials. Pol. Merkuriusz. Lek. 1997; 2(12)396–399
   PubMedGoogle Scholar
• Shimomura K., Manda T., Mukumoto S., Kobayashi K., Nakano K., Mori J. Recombinant human tumor necrosis factor‐alpha: thrombus formation is a cause of anti‐tumor activity. Int. J. Cancer 1988; 41(2)243–247
   PubMedGoogle Scholar
• Nandakumar K. S., Lakshmi R. K., Pardhasaradhi B. V., Khar A. Upregulation of antitumor immunity by IL‐12 gene‐transfected AK‐5 tumor cells in vivo. Cytokines Cell Mol. Ther. 1999; 5(1)7–14
   PubMedGoogle Scholar
• Tasaki K., Yoshida Y., Maeda T., Miyauchi M., Kawamura K., Takenaga K., Yamamoto H., Kouzu T., Asano T., Ochiai T., Sakiyama S., Tagawa M. Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin‐12 or interleukin‐18, which activate type 1 helper T cells. Cancer Gene Ther. 2000; 7(2)247–254
   PubMedGoogle Scholar
• Nishimura T., Nakui M., Sato M., Iwakabe K., Kitamura H., Sekimoto M., Ohta A., Koda T., Nishimura S. The critical role of Th1‐dominant immunity in tumor immunology. Cancer Chemother. Pharmacol. 2000; 46: 52–61
   PubMed Web of Science ®Google Scholar
• Nishioka Y., Hirao M., Robbins P. D., Lotze M. T., Tahara H. Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12. Cancer Res. 1999; 59(16)4035–4041
   PubMed Web of Science ®Google Scholar
• Takeuchi O., Akira S. Genetic approaches to the study of toll‐like receptor function. Microbes. Infect. 2002; 4(9)887–895
   PubMedGoogle Scholar
• Uchiyama M., Ohno N., Miura N. N., Adachi Y., Yadomae T. Anti‐grifolan antibody reacts with the cell wall beta‐glucan and the extracellular mannoprotein‐beta‐glucan complex of C. albicans. Carbohydr. Polymers 2002; 48: 333–340
   Google Scholar
• Adachi Y., Ohno N., Yadomae T. Preparation and antigen specificity of an anti‐(1 → 3)‐beta‐D‐glucan antibody. Biol. Pharm. Bull. 1994; 17(11)1508–1512
   PubMedGoogle Scholar
• Adachi Y., Miura N. N., Ohno N., Tamura H., Tanaka S., Yadomae T. Enzyme immunoassay system for estimating the ultrastructure of (1,6)‐branched (1,3)‐beta‐glucans. Carbohydr. Polymers 1999; 39: 225–229
   Web of Science ®Google Scholar